Related Experiment Video
Updated: Jan 22, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Pediatric pheochromocytoma: current status of diagnostic imaging and treatment procedures
Leslie Peard1, Nicholas G Cost2, Amanda F Saltzman1
1Department of Urology, University of Kentucky, Lexington, Kentucky.
Insights
Pediatric pheochromocytoma (PCC) often has hereditary causes and aggressive features, differing from adult cases. Genetic testing is crucial for diagnosis, screening, and managing this rare tumor in young patients.
Area of Science:
- Pediatric Endocrinology
- Oncology
- Genetics
Background:
- Pediatric pheochromocytoma (PCC) is a rare neuroendocrine tumor.
- Existing knowledge often extrapolates from adult PCC, but pediatric cases present unique characteristics.
Purpose of the Study:
- To review current data on pediatric pheochromocytoma.
- To provide updated management recommendations for pediatric PCC.
Main Methods:
- Literature review of case reports and series on pediatric PCC.
- Analysis of recent findings on genetic syndromes and metastatic disease treatments.
Main Results:
- Pediatric PCC frequently involves hereditary predispositions and aggressive or malignant disease.
- Genetic syndromes are increasingly identified, guiding screening and counseling.
- Advances in treating metastatic PCC are emerging.
- Plasma metanephrines and cross-sectional imaging are key for diagnosis.
- Preoperative medical optimization and surgical resection remain primary treatment modalities.
Conclusions:
- Genetic testing is pivotal in managing pediatric, adolescent, and young adult PCC.
- Understanding hereditary factors and aggressive disease is essential for effective pediatric PCC management.
Purpose Of Review:
To provide an overview of relevant data available and updated recommendations for management of pediatric patients with pheochromocytoma (PCC).
Recent Findings:
Much of the available data surrounding pediatric PCC is in the form of case reports and case series. With the accumulation of data over time, pediatric PCC does in fact differ significantly from not only what is known in the adult population, but also from classic teaching. Pediatric patients are much more likely to have a hereditary predisposition as well as aggressive and malignant disease. Much of the recent literature focuses on defining these genetic syndromes in order to provide recommendations for screening and genetic counseling. Other recent advances center around developing treatments for metastatic disease. Timely diagnosis with plasma metanephrines and cross-sectional imaging, and appropriate preoperative medical optimization followed by surgical resection remain the center of treatment.
Summary:
Although rare and adult principles are applied to pediatric PCC, genetic testing plays a pivotal role in management of children, adolescents and young adults with PCC.
Related Concept Videos
Marcia's Theory of Identity Status
Electrical Current
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Significance of Displacement Current

